Sermorelin 2mg Vial – GHRH(1-29) Peptide

Sermorelin 2mg is a synthetic peptide based on growth hormone-releasing hormone (GHRH). Also known as GHRH(1-29), sermorelin is the biologically active 29-amino-acid fragment of human GHRH and has been studied for its interaction with growth hormone signaling pathways.

The Sermorelin 2mg vial from GenLabMeds is supplied as a lyophilized (freeze-dried) peptide formulation with bacteriostatic water included. It is intended for research use and is provided with product information for researchers evaluating GHRH-related pathways.

Explore our Growth Hormone Peptides collection to discover related research compounds available from GenLabMeds.

Sermorelin 2mg Product Highlights

• 2mg Sermorelin peptide per vial
• GHRH(1-29) peptide
• Synthetic peptide formulation
• Lyophilized, freeze-dried powder
• Bacteriostatic water included
• Suitable for laboratory and research applications
• Part of the GenLabMeds growth hormone peptide collection

What Is Sermorelin?

Sermorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH). Structurally, it corresponds to the biologically active GHRH(1-29) fragment. Researchers interested in related GHRH signaling compounds can also explore CJC-1295. GHRH is involved in signaling the pituitary gland to release growth hormone, making sermorelin an important compound in research involving the growth hormone axis.

Sermorelin has been investigated historically in clinical and research settings, including studies involving growth hormone secretion and growth hormone deficiency. It is also frequently discussed in modern peptide research because of its relationship to the body’s endogenous GH signaling pathway.

How Does Sermorelin Work?

Sermorelin is a GHRH analogue that interacts with the growth hormone-releasing hormone pathway.

In simplified terms, the pathway can be described as:

GHRH signaling → pituitary stimulation → growth hormone release

For researchers exploring complementary growth-hormone-related peptide pathways, see our Ipamorelin research peptide.

This distinguishes sermorelin from recombinant growth hormone. Rather than being growth hormone itself, sermorelin is studied for its role in signaling the body’s natural growth hormone release pathway.

Because of this mechanism, Sermorelin 2mg is commonly included in research involving:

• Growth hormone signaling
• GHRH receptor activity
• Endocrine pathways
• Metabolic research
• Growth and development research
• Peptide pharmacology

Sermorelin 2mg Research Applications

Research involving sermorelin has examined its relationship with growth hormone secretion and the endocrine system.

Another peptide commonly investigated in growth-hormone-related research is Tesamorelin, providing an additional research avenue within this broader peptide category.

Potential research areas include:

Growth Hormone Signaling

Sermorelin provides researchers with a way to study GHRH-related signaling and its relationship with pituitary growth hormone release.

Endocrine Research

Because sermorelin interacts with the GHRH pathway, it can be used in research focused on hormonal signaling and endocrine function.

Peptide Research

Sermorelin is a well-characterized peptide and is commonly discussed alongside other growth hormone-releasing peptides and GHRH analogues.

Metabolic Research

Growth hormone signaling is connected to multiple physiological processes, making the GHRH pathway relevant to broader metabolic research.

Growth and Development Research

Sermorelin has historical clinical research involving growth hormone deficiency and growth-related applications.

Sermorelin vs. Growth Hormone

One important distinction when researching Sermorelin is that sermorelin is not growth hormone.
Researchers comparing different compounds involved in growth-hormone research can explore the HGH Peptides collection for additional information.

Sermorelin is a GHRH analogue that acts within the growth hormone-releasing pathway, while recombinant human growth hormone is the hormone itself.

This difference makes sermorelin useful in research examining the body’s endogenous GH signaling mechanisms rather than simply introducing exogenous growth hormone.

Sermorelin 2mg Specifications

Specification	Details
Product	Sermorelin
Strength	2mg
Peptide	GHRH(1-29)
Form	Lyophilized / freeze-dried powder
Category	Growth hormone-related research peptide
Brand	GenLabMeds
Included	Bacteriostatic water
Intended use	Research use

Why Choose a 2mg Sermorelin Vial?

A 2mg Sermorelin vial provides a defined quantity of peptide for laboratory research and experimentation.

For researchers working with GHRH-related compounds, having a clearly identified peptide strength and formulation makes product selection and inventory management easier.

GenLabMeds provides Sermorelin alongside other peptides used in growth hormone pathway research, including CJC-1295, Ipamorelin, GHRP-2, GHRP-6, and related compounds.

Sermorelin Storage and Handling

Follow the product’s supplied storage and handling instructions.

Lyophilized peptide products should be protected from conditions that can compromise peptide stability. Once a product has been reconstituted, handling and storage requirements may differ from those of the original freeze-dried formulation.

Researchers should always follow applicable laboratory protocols and the manufacturer’s handling information.

Frequently Asked Questions

What is Sermorelin 2mg?

Sermorelin 2mg is a 2mg vial containing sermorelin, a synthetic analogue of growth hormone-releasing hormone. Sermorelin is also known as GHRH(1-29).

What is Sermorelin used for in research?

Sermorelin is studied in research involving GHRH signaling, pituitary growth hormone release, endocrine pathways, and growth hormone-related physiology. Researchers studying related peptide pathways may also be interested in GHRP-2 and GHRP-6

Is Sermorelin the same as HGH?

No. Sermorelin and human growth hormone are different compounds. Sermorelin is a GHRH analogue that is studied for its role in signaling the growth hormone pathway, while HGH is the hormone itself.

What does GHRH(1-29) mean?

GHRH(1-29) refers to the first 29 amino acids of growth hormone-releasing hormone. Sermorelin corresponds to this biologically active fragment.

What comes with the Sermorelin 2mg vial?

The GenLabMeds listing includes a 2mg lyophilized Sermorelin vial with bacteriostatic water.

Is Sermorelin FDA approved?

Sermorelin has a history of FDA-approved use in the United States, but the former Geref products were withdrawn from the U.S. market. Current sermorelin products should not automatically be represented as FDA-approved products.

Order Sermorelin 2mg from GenLabMeds

Explore the Sermorelin 2mg vial from GenLabMeds and review the product specifications, formulation, and research information before ordering.

For researchers exploring the growth hormone signaling pathway, Sermorelin provides a well-characterized GHRH(1-29) peptide for laboratory research applications.

Important: This product is intended for research use only. It is not intended to diagnose, treat, cure, or prevent any disease. Product information does not constitute medical advice. Do not use research products for human or veterinary administration.